1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
LCRF Leading Edge Research Grant Program is sponsored by Lung Cancer Research Foundation. This program funds innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, disparities, and social determinants of health research related to lung cancer. Topics can include lung cancer biology, biomarker identification, machine learning, and therapy development.
The grant supports research to improve outcomes and close gaps in lung cancer care.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Qualified investigators at non-profit institutions worldwide. Post-doctoral researchers and clinical fellows, early-career and mid-career investigators with less than seven years of experience since their initial faculty appointment. Confirm the full requirements in the official notice before applying.
The current listing shows $150,000 over two years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was March 10, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
LCRF Leading Edge Research Grant Program is funded by Lung Cancer Research Foundation. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article